Amgen (NASDAQ: AMGN) announced the submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) via the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE